EDVA · Endovia Health Sciences Inc
United States · RS rating 14 · As of 2026-11-03
| Price | 0.18 USD |
|---|---|
| 1-day change | +2.6% |
| RS rating (overall / 1M / 3M / 12M) | 14 / 79 / 7 / 3 |
| Stage | Declining |
| Composite / Minervini / CANSLIM score | 33 / 17 / 52 |
| Industry group (rank) | Medical-Biomed/Biotech (154) |
| EPS growth Q/Q | +58.0% |
| Sales growth Q/Q | +101.2% |
| Distance from 52-week high | +97.0% |
| Market cap (USD) | $2.0M |